MRNA Went from $63 to $174 in a Day. Now Comes the Real Trade.
The Phase 3 melanoma win validated the mRNA oncology platform. The FDA submission and a pipeline of other cancer trials…
$56B Week Shows Where the Marginal Dollar Went
August 27, 2026 ETF flow data just flashed a leadership signal: hard assets are pulling...
Your Book Is Inside
August 26, 2026 Bonus Content: Crude Down 9%, Airlines Up: Reading the Reversal Sponsored In...
Component Monopolists vs. Boom Renters: Who Keeps the Money
Nvidia’s $108B guide is a cost signal as much as a revenue one. The question is which suppliers can actually…
What the Great Wealth Builders Would Demand Before Backing Starbase Louisiana
SpaceX's $100 billion vertical-integration bet is a masterclass in founder-scale capital allocation. The question is whether the business behind it…
What a 29% Gap Teaches You About Crowded Longs
August 26, 2026 DKS opened down, kept falling, and closed near session lows. The lesson...
UP-NS Decision Pushed to H2 2027
STB calendar extends arb risk into 2027, with Nov. 18 as the first must-watch date.
Why the Richest Man Alive Lives in a $50,000 Shack
August 25, 2026 Bonus Content: What a Split Market Teaches You About a Dated Threat...
The Bond Market Has Already Voted on AVGO. Sept. 2 Is the Recount.
Equity holders have nine days to demand answers on guarantees, leases, and backstops that credit markets are already pricing as…
SPCX Has Round-Tripped. Now the Supply Clock Is Ticking.
August 25, 2026 The Trump disclosure is this week’s headline. The November unlock is the...